Evaluation of allergenic properties and immunotoxicity of dipeptide mimetic of brain-derived neurotrophic factor GSB-106

Abstract. The study of allergenic properties and immunotoxic effects of the ready-to-use drug form of GSB-106 was carried out. The study of allergenic properties and immunotoxicity of GSB-106 was performed on male albino guinea pigs weighing 250-300 g and on male CBA, C57BL / 6, F1 hybrids (CBAxC57B...

Full description

Saved in:
Bibliographic Details
Main Authors: L. P. Kovalenko, K. V. Korzhova, R. V. Zhurikov, C. B. Nikitin, A. D. Durnev
Format: Article
Language:Russian
Published: LLC “Publisher OKI” 2020-07-01
Series:Фармакокинетика и Фармакодинамика
Subjects:
Online Access:https://www.pharmacokinetica.ru/jour/article/view/237
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract. The study of allergenic properties and immunotoxic effects of the ready-to-use drug form of GSB-106 was carried out. The study of allergenic properties and immunotoxicity of GSB-106 was performed on male albino guinea pigs weighing 250-300 g and on male CBA, C57BL / 6, F1 hybrids (CBAxC57BL / 6) mice. When assessing immunotoxicity, GSB-106 was inject to mice per os for 14 days in doses of 2.2 mg / kg and 22 mg / kg. When studying the allergenicity, GSB-106 was injected to albino guinea pigs in doses of 1 mg / kg and 10 mg / kg according to standard regimens of immunization. The results of the study of the immunotoxicity and allergenicity of GSB-106 allow us to conclude that the injection of the ready-to-use drug form of GSB-106 in the range of studied doses does not have an immunotoxic effect and does not have allergenic properties.
ISSN:2587-7836
2686-8830